{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T23:36:06Z","timestamp":1778110566694,"version":"3.51.4"},"update-to":[{"DOI":"10.1002\/14651858.cd007183.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2013,1,31]],"date-time":"2013-01-31T00:00:00Z","timestamp":1359590400000}}],"reference-count":42,"publisher":"Wiley","issue":"1","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd007183.pub3","type":"journal-article","created":{"date-parts":[[2013,1,29]],"date-time":"2013-01-29T08:28:09Z","timestamp":1359448089000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Interventions for HIV-associated nephropathy"],"prefix":"10.1002","volume":"2013","author":[{"given":"Ismail","family":"Yahaya","sequence":"first","affiliation":[{"name":"Save The Youth Initiative; PO Box 3951 Kaduna North Kaduna Nigeria"},{"name":"Mid-Sweden University; Department of Public Health Sciences, Institution for Health Sciences; Sundsvall Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olalekan A","family":"Uthman","sequence":"additional","affiliation":[{"name":"Faculty of Health Sciences, Stellenbosch University; Centre for Evidence-Based Health Care; Francie van Zijl drive Tygerberg Campus Tygerberg Cape Town South Africa 7505"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammed Mubashir B","family":"Uthman","sequence":"additional","affiliation":[{"name":"University of Ilorin Teaching Hospital; Epidemiology and Community Health Department; Ilorin Nigeria"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2013,1,31]]},"reference":[{"issue":"7","key":"10.1002\/14651858.CD007183.pub3-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1681\/ASN.V871140","article-title":"Effect of angiotensin-converting enzyme inhibition in HIV-associated nephropathy","volume":"8","author":"Burns","year":"1997","journal-title":"Journal of the American Society of Nephrology"},{"issue":"2","key":"10.1002\/14651858.CD007183.pub3-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/00000441-200202000-00009","article-title":"Observations on HIV-associated renal disease in the era of highly active antiretroviral therapy","volume":"323","author":"Cosgrove","year":"2002","journal-title":"American Journal of the Medical Sciences"},{"issue":"3","key":"10.1002\/14651858.CD007183.pub3-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1046\/j.1523-1755.2000.00280.x","article-title":"Cohort study of the treatment of severe HIV-associated nephropathy with corticosteroids","volume":"58","author":"Eustace","year":"2000","journal-title":"Kidney International"},{"key":"10.1002\/14651858.CD007183.pub3-BIB0004|cit4","unstructured":"Kalayjian R Phinney M Austen J Gripshover B Carey J Rahman M Prednisone improves renal function in HIV-associated nephropathy (HIVAN) Program and Abstracts of the Second National Congress on Human Retroviruses and Related Infections Washington, DC American Society for Microbiology 1995 154"},{"issue":"4","key":"10.1002\/14651858.CD007183.pub3-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1097\/QAD.0b013e3282f4706d","article-title":"Suppression of HIV-1 replication by antiretroviral therapy improves renal function in persons with low CD4 cell counts and chronic kidney disease","volume":"22","author":"Kalayjian","year":"2008","journal-title":"AIDS"},{"issue":"2","key":"10.1002\/14651858.CD007183.pub3-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/S0272-6386(96)90302-9","article-title":"Captopril and renal survival in patients with human immunodeficiency virus nephropathy","volume":"28","author":"Kimmel","year":"1996","journal-title":"American Journal of Kidney Diseases"},{"issue":"7","key":"10.1002\/14651858.CD007183.pub3-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1038\/ki.2008.305","article-title":"\u00a0Antiretroviral therapy improves renal function among HIV-infected Ugandans\u00a0","volume":"74","author":"Peters","year":"2008","journal-title":"Kidney International"},{"issue":"2","key":"10.1002\/14651858.CD007183.pub3-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0002-9343(94)90024-8","article-title":"Effect of corticosteroid therapy on human immunodeficiency virus-associated nephropathy (HIV-AN)","volume":"97","author":"Smith","year":"1994","journal-title":"American Journal of Medicine"},{"issue":"1","key":"10.1002\/14651858.CD007183.pub3-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0002-9343(96)00065-4","article-title":"Prednisone improves renal function and proteinuria in human immunodeficiency virus-associated nephropathy","volume":"101","author":"Smith","year":"1996","journal-title":"American Journal of Medicine"},{"issue":"3","key":"10.1002\/14651858.CD007183.pub3-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1111\/j.1523-1755.2004.00865.x","article-title":"The clinical epidemiology and course of the spectrum of renal diseases associated with HIV infection","volume":"66","author":"Szczech","year":"2004","journal-title":"Kidney International"},{"issue":"4","key":"10.1002\/14651858.CD007183.pub3-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1046\/j.1523-1755.2003.00230.x","article-title":"Long-term renal survival in HIV-associated nephropathy with angiotensin-converting enzyme inhibition","volume":"64","author":"Wei","year":"2003","journal-title":"Kidney International"},{"key":"10.1002\/14651858.CD007183.pub3-BIB0012|cit12","unstructured":"Keryx Biopharmaceuticals Keryx Biopharmaceuticals to initiate Phase II clinical trial of KRX-101 for the treatment of AIDS-related kidney disease - HIV-associated nephropathy (HIVAN): HIVAN is a life-threatening complication of AIDS (published January 29th 2001) http:\/\/investors.keryx.com\/phoenix.zhtml?c=122201&p=irol-newsArticle_print&ID=869589&highlight="},{"key":"10.1002\/14651858.CD007183.pub3-BIB0013|cit13","unstructured":"Kalayjian R Smith MC Lederman M A phase II randomised, double-blind, placebo-controlled trial to determine the efficacy of prednisolone therapy in HIV-Associated Nephropathy (HIVAN) http:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT00000819"},{"key":"10.1002\/14651858.CD007183.pub3-BIB0014|cit14","unstructured":"Kopp JB Retinoids for minimal change disease and focal segmental glomerulosclerosis http:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT00098020"},{"key":"10.1002\/14651858.CD007183.pub3-BIB0015|cit15","unstructured":"A study of Saquinavir soft gel capsules (SGC) used in combination with two other anti-HIV drugs in patients with HIV-Associated kidney disease http:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT00002397"},{"key":"10.1002\/14651858.CD007183.pub3-BIB0016|cit16","unstructured":"Szczech LA A phase III, randomized, placebo-controlled, double-blind trial of an angiotensin receptor blocker (valsartan) and highly active antiretroviral therapy (HAART) versus HAART alone for the treatment of HIV-associated nephropathy http:\/\/clinicaltrials.gov\/ct2\/show\/NCT00089518"},{"issue":"5","key":"10.1002\/14651858.CD007183.pub3-BIB0017|cit17","first-page":"377","article-title":"Human immunodeficiency virus\/acquired immunodeficiency syndrome-associated nephropathy at end-stage renal disease in the United States: patient characteristics and survival in the pre highly active antiretroviral therapy era","volume":"14","author":"Abbott","year":"2001","journal-title":"Journal of Nephrology"},{"issue":"6","key":"10.1002\/14651858.CD007183.pub3-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1159\/000013537","article-title":"Is the prevalence of HIV-associated nephropathy decreasing?","volume":"19","author":"Ahuja","year":"1999","journal-title":"American Journal of Nephrology"},{"issue":"10","key":"10.1002\/14651858.CD007183.pub3-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.1093\/ndt\/gfl337","article-title":"Antiretroviral therapy in the treatment of HIV-associated nephropathy","volume":"21","author":"Atta","year":"2006","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"3","key":"10.1002\/14651858.CD007183.pub3-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1586\/14787210.6.3.365","article-title":"HIV-associated nephropathy: epidemiology, pathogenesis, diagnosis and management","volume":"6","author":"Atta","year":"2008","journal-title":"Expert Review of Antiinfective Therapy"},{"issue":"3","key":"10.1002\/14651858.CD007183.pub3-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1159\/000112851","article-title":"Observations on a cohort of HIV-infected patients undergoing native renal biopsy","volume":"28","author":"Berliner","year":"2008","journal-title":"American Journal of Nephrology"},{"issue":"4","key":"10.1002\/14651858.CD007183.pub3-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0002-9343(89)80819-8","article-title":"Course and prognosis of human immunodeficiency virus-associated nephropathy","volume":"87","author":"Carbone","year":"1989","journal-title":"American Journal of Medicine"},{"issue":"3","key":"10.1002\/14651858.CD007183.pub3-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1086\/505497","article-title":"HIV Type 1 RNA level as a clinical indicator of renal pathology in HIV-infected patients","volume":"43","author":"Estrella","year":"2006","journal-title":"Clinical Infectious Diseases"},{"issue":"7","key":"10.1002\/14651858.CD007183.pub3-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"963","DOI":"10.2165\/00003495-200868070-00006","article-title":"Renal disease in patients with HIV infection: epidemiology, pathogenesis and management","volume":"68","author":"Fine","year":"2008","journal-title":"Drugs"},{"issue":"10","key":"10.1002\/14651858.CD007183.pub3-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1038\/sj.ki.5000351","article-title":"HIV-related nephropathy: a South African perspective","volume":"69","author":"Gerntholtz","year":"2006","journal-title":"Kidney International"},{"issue":"5","key":"10.1002\/14651858.CD007183.pub3-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1001\/jama.300.5.555","article-title":"Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panel","volume":"300","author":"Hammer","year":"2008","journal-title":"JAMA"},{"issue":"12","key":"10.1002\/14651858.CD007183.pub3-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1038\/sj.ki.5000339","article-title":"A cross-sectional study of HIV-seropositive patients with varying degrees of proteinuria in South Africa","volume":"69","author":"Han","year":"2006","journal-title":"Kidney International"},{"issue":"7414","key":"10.1002\/14651858.CD007183.pub3-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD007183.pub3-BIB0029|cit29","unstructured":"Higgins JP Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"issue":"5","key":"10.1002\/14651858.CD007183.pub3-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/S0022-3476(05)80284-7","article-title":"Nephrotic syndrome associated with acquired immunodeficiency syndrome in children","volume":"119","author":"Ingulli","year":"1991","journal-title":"Journal of Pediatrics"},{"issue":"3","key":"10.1002\/14651858.CD007183.pub3-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1053\/j.ackd.2006.04.013","article-title":"HIV-associated nephropathy","volume":"13","author":"Khan","year":"2006","journal-title":"Advances in Chronic Kidney Disease"},{"issue":"83","key":"10.1002\/14651858.CD007183.pub3-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1046\/j.1523-1755.63.s83.10.x","article-title":"HIV-associated nephropathy in African Americans","author":"Kopp","year":"2003","journal-title":"Kidney International - Supplement"},{"issue":"8","key":"10.1002\/14651858.CD007183.pub3-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/S0929-6646(09)60169-8","article-title":"Human immunodeficiency virus-associated nephropathy","volume":"105","author":"Lai","year":"2006","journal-title":"Journal of the Formosan Medical Association"},{"issue":"3","key":"10.1002\/14651858.CD007183.pub3-BIB0034|cit34","first-page":"259","article-title":"Human immunodeficiency virus-1 associated nephropathy (HIVAN): epidemiology, pathogenesis, histology, diagnosis, and medical management","volume":"33","author":"Lochner","year":"2006","journal-title":"Nephrology Nursing Journal: Journal of the American Nephrology Nurses' Association"},{"issue":"3","key":"10.1002\/14651858.CD007183.pub3-BIB0035|cit35","first-page":"193","article-title":"HIV-associated nephropathy: a brief review","volume":"72","author":"Lu","year":"2005","journal-title":"Mount Sinai Journal of Medicine"},{"issue":"3","key":"10.1002\/14651858.CD007183.pub3-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1097\/00002030-200402200-00022","article-title":"Highly active antiretroviral therapy and the incidence of HIV-1-associated nephropathy: a 12-year cohort study","volume":"18","author":"Lucas","year":"2004","journal-title":"AIDS"},{"issue":"11","key":"10.1002\/14651858.CD007183.pub3-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1056\/NEJM198403153101101","article-title":"Associated focal and segmental glomerulosclerosis in the acquired immunodeficiency syndrome","volume":"310","author":"Rao","year":"1984","journal-title":"New England Journal of Medicine"},{"issue":"10","key":"10.1002\/14651858.CD007183.pub3-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1086\/503566","article-title":"HIV-associated renal diseases and highly active antiretroviral therapy-induced nephropathy","volume":"42","author":"Roling","year":"2006","journal-title":"Clinical Infectious Diseases"},{"issue":"8","key":"10.1002\/14651858.CD007183.pub3-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1086\/424013","article-title":"Association between renal disease and outcomes among HIV-infected women receiving or not receiving antiretroviral therapy","volume":"39","author":"Szczech","year":"2004","journal-title":"Clinical Infectious Diseases"},{"issue":"3","key":"10.1002\/14651858.CD007183.pub3-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1046\/j.1523-1755.1999.0550031036.x","article-title":"HIV-associated nephropathy is a late, not early, manifestation of HIV-1 infection","volume":"55","author":"Winston","year":"1999","journal-title":"Kidney International"},{"issue":"2","key":"10.1002\/14651858.CD007183.pub3-BIB0041|cit41","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007183","article-title":"Adjunctive therapies for HIV-associated nephropathy","author":"Yahaya","year":"2008","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD007183.pub3-BIB0042|cit42","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007183.pub2","article-title":"Interventions for HIV-associated nephropathy","author":"Yahaya","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD007183.pub3\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,26]],"date-time":"2024-12-26T02:32:12Z","timestamp":1735180332000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD007183.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Kidney and Transplant Group","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2013,1,31]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2013,1]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd007183.pub3","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.717985656.793472442","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.717985656.793473115","asserted-by":"object"}]},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1,31]]}}}